Home › ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...
 

Keywords :   


ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...

2015-06-02 00:37:09| Logistics - Topix.net

Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced that results from an ongoing multi-center Phase II study were presented on Saturday, May 30, 2015 at the 2015 American Society for Clinical Oncology annual meeting being held in Chicago. The trial was designed to evaluate the activity of ANG1005, a novel taxane-peptide conjugate able to cross the blood brain barrier and enter cancer cells by targeting the LRP-1 receptor, in metastatic breast cancer patients.

Tags: data cancer presents patients

Category:Transportation and Logistics

Latest from this category

All news
14.11Atlantic Tropical Weather Outlook
14.11Eastern North Pacific Tropical Weather Outlook
14.11Potential Tropical Cyclone Nineteen Graphics
14.11Summary for Potential Tropical Cyclone Nineteen (AT4/AL192024)
14.11Potential Tropical Cyclone Nineteen Public Advisory Number 1A
13.11Potential Tropical Cyclone Nineteen Graphics
13.11Potential Tropical Cyclone Nineteen Forecast Discussion Number 1
13.11Potential Tropical Cyclone Nineteen Wind Speed Probabilities Number 1
Transportation and Logistics »
14.11azutiCORNAGO A2R Tiagra 46s
14.11 /24 24
14.11DS 3DS RPG
14.1138
14.11!! 112+
14.11 R180
14.11
14.11ex sar sr
More »